
Children receiving 50 nmol PVX108 increased their tolerated peanut dose 2.4-fold, with no treatment-related anaphylaxis in the phase 2 trial.
about 18 years ago
CLOUDY CRYSTAL BALLabout 18 years ago
TAX LAW FOR GULLIBLEabout 18 years ago
BOND YIELDS HIT LOWabout 18 years ago
RENTAL RATES RISINGabout 18 years ago
CONFESSING THEIR SINSabout 18 years ago
KEEPING YOUR BALANCEabout 18 years ago
DID YOU KNOW?about 18 years ago
KIDS & FINANCESabout 18 years ago
THE PRESIDENT PAYSabout 18 years ago
SAY NO TO REFINANCING





